-

Eurofins Adds Virus Variant Detection to its SARS-CoV-2 Monitoring Solution for Wastewater, Surface, Air and Worn Masks

LUXEMBOURG--(BUSINESS WIRE)--Eurofins (Paris:ERF) adds virus variant monitoring capabilities to its commercially available SARS-CoV-2 test portfolio. This new solution is part of the Eurofins COVID-19 Sentinel™ and SAFER@WORK™ programs which provide an early warning of the presence of SARS-CoV-2 amongst large populations or at a given site (e.g. a city, factories, education institutions, government and public service sites, nursing homes), before the virus spreads too broadly.

The monitoring of wastewater, environmental surface, air and worn mask testing can give an early indication of the presence of SARS-CoV-2 and can also detect virus variants. This allows for relevant containment measures to be put in place to avoid an outbreak of the disease even before symptom onset.

With a new VIRType kit, Eurofins is now able to rapidly detect and identify between the original SARS-CoV-2 strain (Wildtype) or known variants of interest including the UK (lineage B.1.1.7), South Africa (lineage B.1.351) or Brazil (lineage P.1) variants in wastewater, air, environmental surfaces and worn masks via RT-qPCR. Single point mutations referring to the UK / South Africa / Brazil lineages help to distinguish between the original strain and these SARS-CoV-2 variants.

The Eurofins COVID-19 Sentinel™ program is successfully being used in many countries and communities worldwide as an early and cost-effective indicator of virus presence. In the US, in addition to qualitative surface and worn mask testing the quantification of SARS-CoV-2 in wastewater and air provides crucial information for monitoring viral spread.

For more information, please visit the Eurofins SAFER@WORK website.

About Eurofins – the global leader in bio-analysis

Eurofins is Testing for Life. With over 50,000 staff across a network of more than 800 laboratories in over 50 countries, Eurofins’ companies offer a portfolio of over 200,000 analytical methods.

Eurofins Shares are listed on Euronext Paris Stock Exchange.

Contacts

Eurofins Scientific

BOURSE:ERF

Release Versions

Contacts

More News From Eurofins Scientific

Eurofins Delivers FY 2025 Objectives with a 24% EPS Growth, Accelerating Organic Revenue Growth, Margin Expansion, and Higher Free Cash Flow and Confirms Its 2027 Objectives

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins (Paris:ERF) pre-publishes below its preliminary unaudited consolidated financial results for the year ending 31 December 2025, as described in the first paragraphA of the Business Review section of this press release. Financial highlights in FY 2025 Basic EPS8 grew 24% to €2.31 in 2025 vs €1.87 in 2024, driven by a strong operating performance and starting to reap the benefits from Eurofins five-year investment programme in its hub and spok...

Eurofins: Weekly Report on Share Repurchases From 19th January to 23rd January 2026

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins (Paris:ERF): Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 12/01/2026 FR0014000MR3 5 000 71.7101 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 13/01/2026 FR0014000MR3 5 000 70.5398 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 14/01/...

Eurofins CDMO Alphora Announces Development & Implementation of AI-Powered Salt and Co-Crystal Screening Software

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Eurofins CDMO Alphora is excited to announce the development and launch of a new AI-powered software for high throughput salt and co-crystal screening – now a core component of all solid-state screening programs. Developed by Eurofins CDMO Alphora, in collaboration with a local university, this cutting-edge machine learning platform provides highly accurate predictions of salt and co-crystal formation for APIs and intermediates. This breakthrough technolog...
Back to Newsroom